Tag - South Africa

GHP News Latest Science

Vaccine manufacturer
news briefing
(updated September 22, 2025)

South Africa — Biovac (WHO mRNA hub) Sept 2025 — The Biovac Institute (South Africa) is scaling mRNA manufacturing capacity as a core partner of WHO’s mRNA Technology Transfer Programme, with roles spanning technology...

24 September, 2025

2 min read

Latest Science

Researchers discover a potential vaccine to prevent tuberculosis in people of all ages

In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach. TB remains the leading cause of death by infectious disease globally, with South...

21 June, 2024

3 min read

Latest Science

South Africa: Only a vaccine will break the back of HIV – Health Minister

Health Minister, Dr Aaron Motsoaledi, says South Africans should welcome any initiative aimed at finding an effective HIV vaccine, adding that many battles against diseases were won using vaccines. He was reacting to...

22 July, 2016

2 min read

Latest Science

Pneumococcal vaccine roll out cuts hospitalisations by 70 percent

New data shows that South Africa’s expensive pneumococcal vaccine roll out has cut childhood hospitalisations due to meningitis, pneumonia and rotavirus by 70 percent in just five years, according to Minister of Health...

7 May, 2015

2 min read

Latest Science

Alarming scale of multidrug-resistant Tuberculosis requires rapid response to prevent emerging global crisis

Of the 9.4 million new tuberculosis (TB) cases diagnosed each year, approximately 5% are multidrug resistant (MDR).🔒 Premium Content - For FreeUnlock this content by becoming a Global Health Press subscriber. Join for...

29 March, 2012

4 min read

Tag - South Africa

Vaccine manufacturernews briefing (updated September 22, 2025)

Researchers discover a potential vaccine to prevent tuberculosis in people of all ages

South Africa: Only a vaccine will break the back of HIV – Health Minister

Pneumococcal vaccine roll out cuts hospitalisations by 70 percent

Alarming scale of multidrug-resistant Tuberculosis requires rapid response to prevent emerging global crisis

Vaccine manufacturer
news briefing
(updated September 22, 2025)